Biopsy Devices Market Outlook:
Biopsy Devices Market size was over USD 2.41 billion in 2025 and is projected to reach USD 4.36 billion by 2035, growing at around 6.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of biopsy devices is assessed at USD 2.54 billion.
The market has gained immense expansion opportunities and exposure due to the rising burden of cancer cases, technological advancements, and proceeding diagnostic facilities. There is a surge in the need for biopsy devices due to their large patient pool. According to a WHO report published in 2023, the cancer cases are anticipated to rise by 47.6% from 2020 to 2040, reaching 31 million new cases per year. This global incidence necessitates the demand for advanced biopsy devices. Besides, in 2024, the U.S. NCI reported more than 3 million cancer diagnostics in a year in the U.S. alone. Hence, this is the evidence for increased scope augmenting business in this sector.
Furthermore, the developing nations such as Asia and Africa are at the forefront in the demand for diagnostic devices, aiming to improve healthcare access and raise awareness for early detection of carcinoma to mitigate complications in the long run. Additionally, the research activities are fueling factors of expansion in the industry, with NIH assigned USD 6.7 billion for cancer diagnostics for both liquid biopsy and AI-based pathology. In this regard, the Europe Commission’s Horizon program in 2024 has allocated €1.3 billion to precision medicine tools, such as minimally invasive biopsy devices. Thus, these factors significantly contribute to the market expansion by 2035.
